VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Intertek Group plc vs Novartis AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Intertek Group plc
ITRK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Intertek Group plc's moat claims, evidence, and risks.
View ITRK analysisNovartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisComparison highlights
- Moat score gap: Novartis AG leads (65 / 100 vs 64 / 100 for Intertek Group plc).
- Segment focus: Intertek Group plc has 5 segments (28.3% in Consumer Products); Novartis AG has 5 segments (29.3% in Oncology).
- Moat breadth: Intertek Group plc has 6 moat types across 3 domains; Novartis AG has 4 across 3.
Primary market context
Intertek Group plc
Consumer Products
Consumer products testing, inspection and certification (TIC/ATIC) services
Global
Brands, retailers, manufacturers
Third-party conformity assessment and supply chain QA
28.3%
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Side-by-side metrics
Moat coverage
Shared moat types
Intertek Group plc strengths
Novartis AG strengths
Segment mix
Intertek Group plc segments
Full profile >Consumer Products
Oligopoly
Corporate Assurance
Competitive
Health and Safety
Competitive
Industry and Infrastructure
Competitive
World of Energy
Oligopoly
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.